PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years

dc.contributor.authorStrehlau, Renate
dc.contributor.authorPeña Donati, Anamaría
dc.contributor.authorMartínez Arce, Pedro
dc.contributor.authorLissens, Jürgen
dc.contributor.authorYang, Rong
dc.contributor.authorBiguenet, Sophie
dc.contributor.authorCambilargiu, Daniela
dc.contributor.authorHardy, Hélène
dc.contributor.authorCorrell, Todd
dc.date.accessioned2020-08-29T00:36:27Z
dc.date.available2020-08-29T00:36:27Z
dc.date.issued2015
dc.fechaingreso.objetodigital2025-08-02
dc.format.extent10 páginas
dc.fuente.origenConveris
dc.identifier.doi10.7448/IAS.18.1.19467
dc.identifier.issn1758-2652
dc.identifier.urihttps://doi.org/10.7448/IAS.18.1.19467
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/40715
dc.issue.numeroNo. 1
dc.language.isoen
dc.nota.accesocontenido completo
dc.pagina.final10
dc.pagina.inicio1
dc.revistaJournal of the International AIDS Societyes_ES
dc.rightsacceso abierto
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherVirus de inmunodeficiencia humanaes_ES
dc.subject.otherVIH Chile - Niñoses_ES
dc.subject.otherVIH - Chile - Prevención y controles_ES
dc.subject.otherVIH - Chile - Terapiaes_ES
dc.titlePRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years
dc.typeartículo
dc.volumenVol. 18
sipa.codpersvinculados100172
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PRINCE-1- safety and efficacy of atazanavir powder and ritonavir liquid in HIV.pdf
Size:
360.79 KB
Format:
Adobe Portable Document Format
Description: